The pulmonology devices market size has grown rapidly in recent years. It will grow from $1.5 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising prevalence of respiratory diseases, increasing hospital-based pulmonary procedures, growth in diagnostic bronchoscopy adoption, expansion of pulmonology specialty clinics, availability of advanced airway management devices.
The pulmonology devices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing geriatric population with respiratory disorders, increasing demand for early lung cancer detection, rising adoption of disposable medical devices, expansion of outpatient pulmonary care, technological advancements in pulmonary diagnostics. Major trends in the forecast period include increasing adoption of single-use bronchoscopes, rising demand for minimally invasive pulmonary diagnostics, growing integration of advanced imaging-guided biopsy devices, expansion of portable pulmonary function testing equipment, enhanced focus on infection control and patient safety.
The increasing prevalence of respiratory diseases is anticipated to drive the growth of the pulmonology devices market in the future. Respiratory diseases encompass a range of medical conditions affecting organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The rise in cases of respiratory diseases is due to factors such as increasing air pollution, smoking, and occupational hazards. Pulmonology devices support respiratory disease management by enabling precise diagnosis, continuous monitoring, and effective treatment through tools such as spirometers, inhalers, pulse oximeters, and ventilators, thereby enhancing patient outcomes and quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian health and welfare agency, reported that approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, with asthma and 638,000 people, or 2.5% of the population, with chronic obstructive pulmonary disease (COPD). Therefore, the rise in respiratory disease prevalence is fueling growth in the pulmonology devices market.
Leading companies in the pulmonology devices market are focusing on developing innovative products incorporating advanced technologies to enhance patient comfort, treatment efficacy, and the management of various respiratory conditions. One such technology is bilevel positive airway pressure (BiPAP), which provides two pressure settings - one for inhalation (IPAP) and one for exhalation (EPAP) - offering more comfortable continuous pressure for users. For instance, in February 2024, ResMed, a US-based company specializing in cloud-connected medical devices, launched the AirCurve 11 series of advanced BiPAP machines. The AirCurve 11 VAuto model adjusts pressure during exhalation to align more closely with the patient's natural breathing pattern, enhancing comfort and compliance for conditions such as sleep apnea. Additionally, the AirCurve 11 ASV model utilizes adaptive servo-ventilation (ASV) technology, which monitors and adjusts ventilation 50 times per second to stabilize the patient's breathing patterns. These innovations demonstrate a commitment to improving respiratory care through cutting-edge technologies in pulmonology devices.
In January 2025, Molex LLC, a US-based electronics and manufacturing company, acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Phillips Medisize, Molex’s CDMO arm, significantly strengthened its inhalation drug‑delivery capabilities, enabling an expanded portfolio of combination products and device development. Vectura Group Ltd. is a UK-based pharmaceutical technology company specializing in pulmonology devices, particularly inhalation drug delivery solutions for respiratory conditions such as asthma and COPD.
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Medline Industries LP, Olympus Corporation, Omron Healthcare, ResMed, Getinge, Fisher And Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG And Co. KGaA, NIOX.
North America was the largest region in the pulmonology devices market in 2025. The regions covered in the pulmonology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pulmonology devices market by increasing costs of imported medical-grade polymers, precision components, imaging modules, and electronic subassemblies used in bronchoscopes, biopsy devices, and pulmonary testing systems. Hospitals and clinics in North America and Europe are most affected due to reliance on imported diagnostic and therapeutic devices, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are contributing to higher procurement costs and delayed equipment upgrades. However, they are also encouraging localized device manufacturing, regional supplier development, and increased investment in domestic production capabilities for critical pulmonology equipment.
The pulmonology devices market research report is one of a series of new reports that provides pulmonology devices market statistics, including pulmonology devices industry global market size, regional shares, competitors with a pulmonology devices market share, detailed pulmonology devices market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonology devices industry. This pulmonology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pulmonology devices encompass medical instruments and equipment employed for diagnosing, treating, and managing respiratory system conditions and diseases. These devices are essential for evaluating lung function, monitoring respiratory health, administering therapeutic interventions, and supporting patients with respiratory disorders.
Key products within the pulmonology devices market include endobronchial ultrasound (EBUS) needles, pulmonary biopsy devices, airway stents, single-use bronchoscopes, and other specialized tools. EBUS needles, utilized during bronchoscopy, are designed for collecting tissue samples from the lungs and nearby lymph nodes. They are used in various conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, tracheal and bronchial stenosis, foreign body extraction, among others. These devices find application in pulmonology clinics, hospitals, and ambulatory surgical centers.
The pulmonary devices market consists of sales of spirometers, peak flow meters, nebulizers, and pulse oximeters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pulmonology devices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing geriatric population with respiratory disorders, increasing demand for early lung cancer detection, rising adoption of disposable medical devices, expansion of outpatient pulmonary care, technological advancements in pulmonary diagnostics. Major trends in the forecast period include increasing adoption of single-use bronchoscopes, rising demand for minimally invasive pulmonary diagnostics, growing integration of advanced imaging-guided biopsy devices, expansion of portable pulmonary function testing equipment, enhanced focus on infection control and patient safety.
The increasing prevalence of respiratory diseases is anticipated to drive the growth of the pulmonology devices market in the future. Respiratory diseases encompass a range of medical conditions affecting organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The rise in cases of respiratory diseases is due to factors such as increasing air pollution, smoking, and occupational hazards. Pulmonology devices support respiratory disease management by enabling precise diagnosis, continuous monitoring, and effective treatment through tools such as spirometers, inhalers, pulse oximeters, and ventilators, thereby enhancing patient outcomes and quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian health and welfare agency, reported that approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, with asthma and 638,000 people, or 2.5% of the population, with chronic obstructive pulmonary disease (COPD). Therefore, the rise in respiratory disease prevalence is fueling growth in the pulmonology devices market.
Leading companies in the pulmonology devices market are focusing on developing innovative products incorporating advanced technologies to enhance patient comfort, treatment efficacy, and the management of various respiratory conditions. One such technology is bilevel positive airway pressure (BiPAP), which provides two pressure settings - one for inhalation (IPAP) and one for exhalation (EPAP) - offering more comfortable continuous pressure for users. For instance, in February 2024, ResMed, a US-based company specializing in cloud-connected medical devices, launched the AirCurve 11 series of advanced BiPAP machines. The AirCurve 11 VAuto model adjusts pressure during exhalation to align more closely with the patient's natural breathing pattern, enhancing comfort and compliance for conditions such as sleep apnea. Additionally, the AirCurve 11 ASV model utilizes adaptive servo-ventilation (ASV) technology, which monitors and adjusts ventilation 50 times per second to stabilize the patient's breathing patterns. These innovations demonstrate a commitment to improving respiratory care through cutting-edge technologies in pulmonology devices.
In January 2025, Molex LLC, a US-based electronics and manufacturing company, acquired Vectura Group Ltd. for an undisclosed amount. Through this acquisition, Phillips Medisize, Molex’s CDMO arm, significantly strengthened its inhalation drug‑delivery capabilities, enabling an expanded portfolio of combination products and device development. Vectura Group Ltd. is a UK-based pharmaceutical technology company specializing in pulmonology devices, particularly inhalation drug delivery solutions for respiratory conditions such as asthma and COPD.
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Medline Industries LP, Olympus Corporation, Omron Healthcare, ResMed, Getinge, Fisher And Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG And Co. KGaA, NIOX.
North America was the largest region in the pulmonology devices market in 2025. The regions covered in the pulmonology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pulmonology devices market by increasing costs of imported medical-grade polymers, precision components, imaging modules, and electronic subassemblies used in bronchoscopes, biopsy devices, and pulmonary testing systems. Hospitals and clinics in North America and Europe are most affected due to reliance on imported diagnostic and therapeutic devices, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are contributing to higher procurement costs and delayed equipment upgrades. However, they are also encouraging localized device manufacturing, regional supplier development, and increased investment in domestic production capabilities for critical pulmonology equipment.
The pulmonology devices market research report is one of a series of new reports that provides pulmonology devices market statistics, including pulmonology devices industry global market size, regional shares, competitors with a pulmonology devices market share, detailed pulmonology devices market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonology devices industry. This pulmonology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pulmonology devices encompass medical instruments and equipment employed for diagnosing, treating, and managing respiratory system conditions and diseases. These devices are essential for evaluating lung function, monitoring respiratory health, administering therapeutic interventions, and supporting patients with respiratory disorders.
Key products within the pulmonology devices market include endobronchial ultrasound (EBUS) needles, pulmonary biopsy devices, airway stents, single-use bronchoscopes, and other specialized tools. EBUS needles, utilized during bronchoscopy, are designed for collecting tissue samples from the lungs and nearby lymph nodes. They are used in various conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, tracheal and bronchial stenosis, foreign body extraction, among others. These devices find application in pulmonology clinics, hospitals, and ambulatory surgical centers.
The pulmonary devices market consists of sales of spirometers, peak flow meters, nebulizers, and pulse oximeters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pulmonology Devices Market Characteristics
3. Pulmonology Devices Market Supply Chain Analysis
4. Global Pulmonology Devices Market Trends and Strategies
5. Pulmonology Devices Market Analysis of End Use Industries
7. Global Pulmonology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pulmonology Devices Total Addressable Market (TAM) Analysis for the Market
9. Pulmonology Devices Market Segmentation
10. Pulmonology Devices Market Regional and Country Analysis
11. Asia-Pacific Pulmonology Devices Market
12. China Pulmonology Devices Market
13. India Pulmonology Devices Market
14. Japan Pulmonology Devices Market
15. Australia Pulmonology Devices Market
16. Indonesia Pulmonology Devices Market
17. South Korea Pulmonology Devices Market
18. Taiwan Pulmonology Devices Market
19. South East Asia Pulmonology Devices Market
20. Western Europe Pulmonology Devices Market
21. UK Pulmonology Devices Market
22. Germany Pulmonology Devices Market
23. France Pulmonology Devices Market
24. Italy Pulmonology Devices Market
25. Spain Pulmonology Devices Market
26. Eastern Europe Pulmonology Devices Market
27. Russia Pulmonology Devices Market
28. North America Pulmonology Devices Market
29. USA Pulmonology Devices Market
30. Canada Pulmonology Devices Market
31. South America Pulmonology Devices Market
32. Brazil Pulmonology Devices Market
33. Middle East Pulmonology Devices Market
34. Africa Pulmonology Devices Market
36. Pulmonology Devices Market Competitive Landscape and Company Profiles
37. Pulmonology Devices Market Other Major and Innovative Companies
40. Pulmonology Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pulmonology Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pulmonology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pulmonology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Endobronchial Ultrasound (EBUS) Needles; Pulmonary Biopsy Devices; Airway Stents; Single-Use Bronchoscopes; Other Product Types2) By Indication: Chronic Obstructive Pulmonary Disease (COPD); Lung Cancer; Tracheal And Bronchial Stenosis; Foreign Body Extraction; Other Indications
3) By End-User: Pulmonology Clinics; Hospitals; Ambulatory Surgical Centers
Subsegments:
1) By Endobronchial Ultrasound (EBUS) Needles: Radial EBUS Needles; Linear EBUS Needles; Biopsy EBUS Needles; EBUS Needles With Safety Features; EBUS Needles For Peripheral Lung Lesions2) By Pulmonary Biopsy Devices: Core Biopsy Needles; Fine Needle Aspiration (FNA) Biopsy Devices; Vacuum-Assisted Biopsy Devices; Transthoracic Biopsy Devices; Endoscopic Pulmonary Biopsy Devices
3) By Airway Stents: Self-Expanding Airway Stents; Balloon-Expandable Airway Stents; Silicone Airway Stents; Metal Airway Stents; Hybrid Airway Stents (Silicone + Metal)
4) By Single-Use Bronchoscopes: Single-Use Flexible Bronchoscopes; Single-Use Rigid Bronchoscopes; Single-Use Pediatric Bronchoscopes; Single-Use Disposable Video Bronchoscopes; Single-Use Bronchoscopes With Integrated Suction
5) By Other Product Types: Pulmonary Function Testing Devices; Nebulizers For Pulmonary Disease Treatment; Spirometers; Pulmonary Inhalation Devices; Non-Invasive Ventilation (NIV) Devices
Companies Mentioned: Medtronic; Koninklijke Philips N.V.; GE Healthcare; Boston Scientific Corporation; Medline Industries LP; Olympus Corporation; Omron Healthcare; ResMed; Getinge; Fisher And Paykel Healthcare Limited; Ambu A/S; Vyaire Medical Inc.; Drive DeVilbiss Healthcare; PENTAX Medical; Hamilton Medical; Nonin Medical; CAIRE Inc.; Pulmonx Corporation; Verathon Inc.; Draegerwerk AG And Co. KGaA; NIOX
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pulmonology Devices market report include:- Medtronic
- Koninklijke Philips N.V.
- GE Healthcare
- Boston Scientific Corporation
- Medline Industries LP
- Olympus Corporation
- Omron Healthcare
- ResMed
- Getinge
- Fisher And Paykel Healthcare Limited
- Ambu A/S
- Vyaire Medical Inc.
- Drive DeVilbiss Healthcare
- PENTAX Medical
- Hamilton Medical
- Nonin Medical
- CAIRE Inc.
- Pulmonx Corporation
- Verathon Inc.
- Draegerwerk AG And Co. KGaA
- NIOX
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.66 Billion |
| Forecasted Market Value ( USD | $ 2.36 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
